GL1X · GenesisL1 explorer

MolNFT v1 · #106057 · protein

Crystal structure of broadly neutralizing anti-HIV antibody PGT130

4RNR · PGT130 heavy chain: “Crystal structure of broadly neutralizing anti-HIV antibody PGT130”. X-ray diffraction, 1 ligand (NAG), 8 pockets (best druggability 0.62). MolNFT v1 #106057 on GenesisL1: 3D structure, binding sites and pockets…

PDB
4RNR
Type
protein
Length
859 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
PGT130 heavy chain; PGT130 light chain
Ligands
NAG
Pockets
8 · best druggability 0.62

Structure

x-ray diffraction · 3 distinct chains · 7% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APGT130 heavy chainprotein2187% helix, 53% strand—
B, DPGT130 light chainprotein2128% helix, 52% strand—
CPGT130 heavy chainprotein2176% helix, 51% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains A, B, D, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15970.620.7452empty
25670.620.7463empty
33160.590.7837NAG
43140.560.7645NAG
51230.450.7827empty

Interfaces

3 interfaces between chains.

  • C–D · 1832 Ų buried · 13 hydrogen bonds · protein-protein
  • A–B · 1779 Ų buried · 12 hydrogen bonds · protein-protein
  • B–D · 713 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide, 4 glycan (disulfide, N-glycosylation).

Compared structures

  • 4RNR · Crystal structure of broadly neutralizing anti-HIV antibody PGT130 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.